Role of Oral Iron in Patients with Heart Failure and Iron Deficiency in Tanzania

Role of Oral Iron in Patients with Heart Failure and Iron Deficiency in Tanzania: The Prospective Tanzania Heart Failure-Oral Iron Pilot Clinical Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201508001219405

Enrollment

102

Registered

2015-07-26

Start date

2015-01-07

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Nutritional, Metabolic, Endocrine Heart failure , iron deficiency

Interventions

None

oral ferrous sulphate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ¿Diagnosis of stable heart failure (both with reduced and preserved EF) based on Echo and NT-proBNP >300 ng/L ¿Iron deficiency defined as: serum ferritin level <100 ¿g/L or 100 - 299 ¿g/L with concurrent transferrin saturation <20%.

Exclusion criteria

Exclusion criteria: ¿Age 15g/dl ¿Consent is not given

Design outcomes

Primary

Measure	Time frame
increase in mean serum ferritin	—

Secondary

Measure	Time frame
increase in mean left ventricular ejection fraction;dencrease in mean NT-ProBNP levels ;increase in mean hemoglobin;increase in mean 6-Minutes-Walk distance	—

Countries

Tanzania

Contacts

Public ContactJulie Makani

Muhimbili University of Health and Allied Sciences

makubi55@gmail.com255754381551

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026